These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologies. Hardman TC; Thomas T; Lant AF J Membr Biol; 1998 Jan; 161(2):197-205. PubMed ID: 9435275 [TBL] [Abstract][Full Text] [Related]
9. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy. Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R Clin Sci (Lond); 1992 Mar; 82(3):301-7. PubMed ID: 1312415 [TBL] [Abstract][Full Text] [Related]
10. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients. Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253 [TBL] [Abstract][Full Text] [Related]
11. Thiol group modulation of sodium-lithium countertransport kinetics in diabetic nephropathy. Jones SC; Thomas TH; Marshall SM Diabetologia; 1997 Sep; 40(9):1079-84. PubMed ID: 9300245 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension. Hardman TC; Wierzbicki AS; Croft P; Feher M; Cox A; Lant AF J Hum Hypertens; 1996 Jun; 10(6):429-30. PubMed ID: 8872813 [TBL] [Abstract][Full Text] [Related]
13. Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy. Vervoort G; Elving LD; Wetzels JF; Lutterman JA; Smits P; de Pont JJ; Berden JH Eur J Clin Invest; 2002 Feb; 32(2):93-9. PubMed ID: 11895455 [TBL] [Abstract][Full Text] [Related]
14. Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial. Mead PA; Wilkinson R; Thomas TH Diabetes Care; 2001 Mar; 24(3):527-32. PubMed ID: 11289480 [TBL] [Abstract][Full Text] [Related]
15. Erythrocyte sodium-lithium countertransport, adenosine triphosphatase activity and sodium-potassium fluxes in insulin-dependent diabetes. Besch W; Blücher H; Bettin D; Wolf E; Michaelis D; Kohnert KD Int J Clin Lab Res; 1995; 25(2):104-9. PubMed ID: 7663004 [TBL] [Abstract][Full Text] [Related]
16. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644 [TBL] [Abstract][Full Text] [Related]
17. Nephropathy and changes in sodium-lithium countertransport kinetics in type 2 (non-insulin-dependent) diabetes mellitus. Rutherford PA; Thomas TH; Taylor R; Wilkinson R J Hum Hypertens; 1994 Jan; 8(1):29-35. PubMed ID: 8151603 [TBL] [Abstract][Full Text] [Related]
18. Catamenial variations in erythrocyte sodium-lithium countertransport and blood pressure. Adebayo GI; Hemeryck L; Hall M; Gasparro D; Sinnott M; Feely J Clin Sci (Lond); 1997 Jul; 93(1):29-34. PubMed ID: 9279200 [TBL] [Abstract][Full Text] [Related]
19. Sodium-lithium transport in adolescents with IDDM. Relationship to incipient nephropathy and glycemic control. Crompton CH; Balfe JW; Balfe JA; Chatzilias A; Daneman D Diabetes Care; 1994 Jul; 17(7):704-10. PubMed ID: 7924781 [TBL] [Abstract][Full Text] [Related]
20. The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Pinkney JH; Foyle WJ; Denver AE; Mohamed-Ali V; McKinlay S; Yudkin JS Diabetologia; 1995 Mar; 38(3):356-62. PubMed ID: 7758884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]